Collaborative innovation in small batch manufacturing

flexible production cell

Small filling runs create unique challenges. See how Vetter and Syntegon are combining their expertise to solve them

As the biopharma industry increases its focus on rare diseases, the global drug pipeline is rapidly filling with a sophisticated new wave of orphan products. Highly sensitive and increasingly complex, these products are often produced in small-scale batches that put CDMOs’ technical and economical expertise to the test.

Vetter and Syntegon are rising to the challenge, and pursuing a new industry standard in small-batch manufacturing. With combined expertise in fill-and-finish, system process design, and plant technology, our teams are collaborating on an innovative, flexible, cGMP-compliant filling concept for small batch sizes.

Learn more in this new industry article from Arno Schroff, Director Site & Plant Development at Vetter.

Read now